Novo Nordisk (Finland)

Recent papers from Novo Nordisk (Finland)

1. Depot-specific molecular remodelling of human adipose tissue and liver following bariatric surgery revealed by longitudinal multi-omic profilingMetabolism · 2026
2. The perineurium integrates leptin with its sympathetic outflow to protect against obesityNature Metabolism · 2026
3. Weight change and short-term risk of hypertension in healthy adultsEuropean Journal of Preventive Cardiology · 2026
4. Order Effects and Teacher Labor Supply: A Nationwide RCT in EcuadorAmerican Economic Journal Applied Economics · 2026
5. Empowering digital health management with on-device large language models for glucose prediction: a model development and validation studyEBioMedicine · 2026
6. Nationwide Real‐World Retrospective Study of Oral Semaglutide Use in Adults Living With Type 2 Diabetes in F inlandDiabetes Obesity and Metabolism · 2026
7. Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasomeCell · 2026
8. Oral semaglutide reduces diabetes-related distress in adults with type 2 diabetes mellitus switching from DPP-4 inhibitors. The DOORS prospective real-world Italian studyDiabetes Research and Clinical Practice · 2026
9. Exome sequencing and analysis of 44,028 British South Asians enriched for high autozygosityNature Genetics · 2026
10. Genetics of skeletal proportions across two different populationsThe American Journal of Human Genetics · 2026
11. Demographic Change in Prevalent Type 1 Diabetes Adult Population, and Association of Risk Factors With Comorbidities and Mortality—Results From the Finnish Diabetes Control Study FinDiConDiabetes Obesity and Metabolism · 2026
12. Multimorbidity trajectories and their sex-specific impacts on risk of mortality and re-hospitalisationScientific Reports · 2026
13. Uncomplicated and Complicated Acute Appendicitis Induce Different Cytokine PatternsApmis · 2026
14. Distinct radial glia subtypes regulate midbrain dopaminergic neuron developmentNature Neuroscience · 2026
15. Human‐derived cardiac‐neural microtissues reveal catecholaminergic polymorphic ventricular tachycardia is also a disease of the sympathetic neuronThe Journal of Physiology · 2026
16. Genetics identifies obesity as a shared risk factor for co-occurring multiple long-term conditionsCommunications Medicine · 2026
17. Deciphering tissue-specific protein regulation for insights into cardiometabolic diseaseMolecular Metabolism · 2025
18. UK Biobank: Transforming drug discovery and precision medicineBritish Journal of Pharmacology · 2025
19. Age-specific changes in obesity and associated cardiometabolic risk factors: a two-decade study of the Finnish adultsEuropean Journal of Public Health · 2025
20. The combination of zalfermin and semaglutide has additive therapeutic effects in a diet-induced obese and biopsy-confirmed mouse model of MASHPLoS ONE · 2025